Biotech & Bioprocessing

Synthetic Biology Revolutionizes Sustainable Food Production
Biotech & Bioprocessing Synthetic Biology Revolutionizes Sustainable Food Production

The dawn of a food revolution is upon us, with synthetic biology at the helm, ready to address critical issues like resource scarcity and population growth. The anticipated SynBioBeta 2024's food and ag panel sessions are likely to showcase significant advances in synthetic biology, signaling a

Is Synthetic Biology the Frontier for Future Investments?
Biotech & Bioprocessing Is Synthetic Biology the Frontier for Future Investments?

Synthetic biology stands at the vanguard of biotechnology, offering a future where the creation and manipulation of life are not confined to the boundaries of natural evolution. Unlike traditional gene editing, which typically involves small-scale modifications, synthetic biology ambitiously seeks

How Will StemFit™ Basic04 CT Transform iPSC Research?
Biotech & Bioprocessing How Will StemFit™ Basic04 CT Transform iPSC Research?

The evolution of induced pluripotent stem cell (iPSC) culture is set to be revolutionized with the introduction of AMSBIO's StemFit™ Basic04 CT. This innovative cell culture medium, compliant with Good Manufacturing Practice (GMP) standards, is designed to significantly improve the cultivation and

Revolutionizing Cell Bank Testing with Aptegra™ CHO Assay
Biotech & Bioprocessing Revolutionizing Cell Bank Testing with Aptegra™ CHO Assay

In the realm of biopharmaceutical manufacturing, the genetic integrity of cell banks is paramount to ensuring the safety and efficacy of biological products. Traditional methods for testing the genetic stability of CHO (Chinese Hamster Ovary) involve a suite of assays, each designed to address

Is Novartis Reshaping Ties with China Over the BIOSECURE Act?
Biotech & Bioprocessing Is Novartis Reshaping Ties with China Over the BIOSECURE Act?

Navigating Regulatory Expectations Proactive Measures for Compliance Novartis is adjusting its Chinese partnerships due to a proposed U.S. bill, the BIOSECURE Act, aimed at foreign biotech firms with potential security risks. While the act isn't law yet, Novartis is taking preemptive action to

Revolutionizing Cell Culture: AI and Automation Merge
Biotech & Bioprocessing Revolutionizing Cell Culture: AI and Automation Merge

Revolutionizing Cell Culture: AI and Automation Merge The realm of life sciences research has been on the cusp of a paradigm shift with the integration of artificial intelligence (AI) and automation in cell culture technology. Cell culture, central to pathbreaking scientific and therapeutic

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later